Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

12 déc. 2017 16h19 HE | Source: Provectus Biopharmaceuticals Inc.

PROVECTUS Announces Resolution of SEC Investigation

– SEC “takes into account the proactive remediation and cooperation by the [C]ompany’s new leadership” – – No monetary penalties; Commission notes actions already taken by Provectus to remedy...
30 nov. 2017 06h00 HE | Source: Provectus Biopharmaceuticals Inc.

PROVECTUS ANNOUNCES RESULTS FROM MECHANISM OF ACTION STUDY OF TOPICAL PH-10 FOR THE TREATMENT OF PSORIASIS

– Responses mediated by multiple pathways, including IL-17, IL-22 and interferons – – Down-regulation of more than 500 disease-related genes; wide range of central “psoriasis-related” genes...